Browsed by
Tag: Immunotherapy

Boost skin cancer immunotherapy by targeting proteins.

Boost skin cancer immunotherapy by targeting proteins.

Comments 0 Comment

A protein that aids tumors in evading immune response and supports the growth of melanoma has been discovered by new research.

According to researchers, immunotherapy should be more effective with tailored medicines directed particularly at this protein.

One of the most prevalent malignancies, melanoma is typically brought on by exposure to UV light, while hereditary factors also play a part in its development.

Experts advise staying away from tanning beds and direct sunshine, as well as keeping an eye out for any moles that seem out of the ordinary.

The growth of melanoma has been the subject of recent research, which has also opened up new potential treatment options.

In a study that was published in the journal Science Advances, researchers showed how a protein called NR2F6 aids tumor growth by assisting tumours to elude the immune system.

The scientists discovered that in mice, eliminating the protein made the immune treatment work more effectively.

“This tells us that NR2F6 helps melanoma evade the immune system, and without it, the immune system can more readily suppress tumour growth,” said Dr. Hyungsoo Kim, a research assistant professor at Sanford Burnham Prebys, a research centre in La Jolla, California, and the study’s first author.

Treatments that prevent the protein’s action are thought to be twice as effective since it behaves the same way whether it is in a tumor or the tissues around it.

The scientists are currently searching for fresh medications that can particularly target NR2F6.

learning about melanoma

Melanoma develops when the DNA in skin cells is harmed, according to dermatologist Dr. Ahmad Chaudhry of the United Kingdom, who spoke to us.

According to Chaudhry, exposure to ultraviolet (UV) light from the sun or tanning booths is frequently to blame for this. “Due to this damage, the melanocytes (cells that produce melanin) proliferate out of control and aggregate into a mass of malignant cells. The development of melanoma in the eyes or internal organs does occur occasionally, but it is less frequent.”

While there are some hereditary risk factors that can potentially play a role, sunshine and tanning beds are linked to skin cancer for a reason.

We were informed by Dr. Sudarsan Kollimuttathuillam, a medical oncologist and haematologist at the City of Hope cancer research organization’s Huntington Beach and Irvine Sand Canyon locations, that 7% to 15% of people with melanoma also have a family member who has the condition.

According to him, having characteristics like pale skin, freckles, or blonde or red hair raises one’s overall risk of developing skin cancer. Atypical mole syndrome is another genetic disorder that dramatically raises the lifetime risk of melanoma and is characterized by a high number of moles with odd forms or color.

Risk can be reduced, but genetics cannot be changed. Doctors advise limiting exposure to the sun during peak hours, staying away from tanning beds in general, and wearing sun protection when outdoors to reduce your risk of acquiring skin cancer.

In the words of Kollimuttathuillam, “regular skin examinations by both you and a dermatologist will help detect melanoma at an early stage, when it is more treatable.”

Experiencing melanoma

One of the most prevalent types of cancer are skin malignancies like melanoma.

More than 97,000 Americans are expected to receive melanoma diagnoses in the US in 2023, according to the American Cancer Society.

As previously mentioned, melanoma can be detected early by a number of telling indications, including genetics and moles. The following procedure usually entails removing and then examining the mole if a doctor suspects it may be malignant. Melanoma presence or absence can be assessed by a range of tests.

It’s crucial to get an early diagnosis of melanoma because it spreads quickly.

According to Kollimuttathuillam, melanoma is the type of skin cancer that is most likely to spread to distant organs or bones. Because of this, imaging technologies may be utilized to spot cancer cells that have done so.

After receiving a melanoma diagnosis, a patient has a variety of treatment choices at their disposal, including radiation therapy, surgery, and immunotherapy.

In the earliest stages of melanoma, patients typically do not require imaging tests because, as Kollimuttathuillam noted, “we know that the best way to stop cancer is to prevent it.” “I cannot emphasize enough how crucial it is for patients to be advocates for their skin health to avoid advanced stages of this disease,” the doctor said.

Types of Immunotherapy

Medication is used in immunotherapy to boost your immune system. This might aid in its attack on cancer cells.

Severe melanoma is treated with a variety of immunotherapies, including:

Checkpoint blockers. The PD-1 blockers nivolumab (Opdivo) and pembrolizumab (Keytruda) as well as the CTL4-blocker ipilimumab (Yervoy) are among these drugs. These medications could aid T cells in your immune system in identifying and eliminating melanoma cancer cells.

Oncolytic virus therapy. In this procedure, melanoma tumors are injected with talimogene laherparepvec (T-VEC, Imylgic), a modified virus. In addition to killing cancer cells, this virus may also cause your immune system to fight cancer cells.

Cytokine therapy. Immune cells can interact with one another with the aid of a class of proteins called cytokines. Interleukin-2 (aldesleukin, proleukin) therapy may enhance your immune system’s defense against cancer.

Your doctor may recommend a single immunotherapy treatment or a cocktail of immunotherapy medications. They might prescribe Yervoy and Opdivo combined, for instance.

Individuals with stage 4 melanoma now have better survival rates thanks to immunotherapy. However, there is a chance that this treatment will have negative side effects.

Contact your doctor straight away if you suspect any potential side effects.

REFERENCES:

For Skin cancer medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=10

How gut bacteria can boost cancer immunotherapy efficacy?

How gut bacteria can boost cancer immunotherapy efficacy?

Comments 0 Comment

Researchers looked into how gut bacteria affected mice’s response to immune checkpoint inhibitor (ICI) therapy. They discovered that ICIs enable specific gut bacteria to get through tumor locations. It then stimulates the immune system, which then destroys cancer cells.

To confirm whether these results may apply to humans, more research is required.

Immunotherapy includes the use of immune checkpoint inhibitors (ICIs). They function by “taking the brakes off” of the immune system so it can eliminate cancer cells by blocking certain proteins that restrict immune function, such as CTLA-4 or PD-1.

Unfortunately, ICI therapies are ineffective in up to 50% of cancer patients. The effectiveness of ICI treatment may be influenced by the gut flora, according to a growing body of research.

According to research, animals with impaired gut flora or those given antibiotic treatment react to ICI less favourably. Studies have also shown that faecal transplants of new microbiota may improve ICI responsiveness.

The best gut bacteria for boosting ICI response and the mechanism by which gut bacteria enhance immune response are still unknown.

Immune Checkpoint Inhibitors(ICI) and gut bacteria

Recent studies examined the relationship between gut bacterial diversity and ICI effectiveness in a mouse model of melanoma.

They discovered that ICI treatment results in gastrointestinal inflammation. This allows bacteria to get through the intestines. Thereby moves to lymph nodes close to tumors where they activate immune cells.

The research is published in Science Immunology. Even though checkpoint inhibitor treatment has demonstrated unheard-of clinical success, a sizable portion of responders will later develop acquired resistance. As previously mentioned, the gut microbiota has a significant impact on host anti-tumor immunity in several ways. This affects the clinical reactions and outcomes of cancer immunotherapy patients.

Dr. Anton Bilchik, chief of medicine and director of the Gastrointestinal and Hepatobiliary Program at Saint John’s Cancer Institute in Santa Monica, California, as well as a surgical oncologist and division chair of general surgery at Providence Saint John’s Health Center, did not take part in the study.

Investigating ICI efficacy

Mice with and without melanoma tumours received ICI therapy as part of the study.

They discovered that ICI treatment exacerbated gastrointestinal inflammation, allowing certain bacteria to pass from the gut to lymph nodes close to the tumour as well as the tumour site. In that location, the bacteria triggered a group of immune cells that destroyed tumour cells.

The effectiveness of ICI may be impacted by antibiotic exposure, according to the study. To do this, mice were first given antibiotic treatment. Further followed by melanoma tumor implantation and ICI treatment a week later.

They discovered that exposure to antibiotics lowered the number of immune cells and the migration of the gut microbiota to the lymph nodes.

Finally, they looked at whether giving out certain bacteria may counteract the effect of the antibiotics on the effectiveness of the ICI. They discovered that using Escherichia coli and Enterococcus faecalis in treatments increased ICI effectiveness.

Fecal microbiome transplantation

FMT is the most direct way to change the microbiota. Feces from one donor is given to another by lyophilized or frozen pills that are taken orally. Also, they can be delivered directly via colonoscopy or gastroscopy.

With almost 300 registered clinical trials as of now, FMTs are being investigated as a treatment alternative for an increasing range of illnesses (clinicaltrials.gov, accessed Aug 2021). Over the past ten years, it has been clear that FMTs are extraordinarily effective at treating resistant and recurring Clostridium difficile infections. This helps patients feel better and get rid of their clinical symptoms.

Dietary intervention and lifestyle

The relationship between diet and the microbiota has been studied for numerous years at various resolution levels because gut microbes have a role in food digestion. In fact, distinct microbial communities are closely involved in the sequential host digestion and nutrient extraction, with the gut microbiota playing the major role.

On the one hand, the host’s inability to digest a large number of chemicals released by the gut microbiota affects the food’s ability to provide nutrients. Contrarily, both short- and long-term dietary modifications can affect the microbial transcriptome and metabolomic profiles, especially for newborn nutrition. This may have long-term effects through microbial modulation of the immune system. For instance, high-fat diets are linked to significant changes in the makeup of the colonic microbiota. This includes decreases in both Gram-positive.

Study restrictions

Dr. Andrew Koh, senior author of the present work and associate professor at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, was contacted by MNT to discuss its limitations.

They only employed one preclinical cancer model, which, according to Dr. Koh, is a significant restriction, necessitating additional research to see whether the results also apply to other cancers.

Although we have not yet produced evidence to support that notion, we think that our findings may also be applicable to other tumours, he said.

According to published research, various human cancers include specific or unique tumour microbiomes, and many of the prominent taxa are bacteria that normally live in the gut. Dr. Bilchik stated that it is still unclear whether the results apply to people when asked about the study’s other limitations.

Interventional gastroenterologist Dr. Lance Uradomo, who is not affiliated with the study and practice in Irvine, California at the City of Hope Orange County Lennar Foundation Cancer Center, stated that “the type of therapy applied for testing melanoma can be linked to adverse side effects, such as colitis.”

Before it is known if microbiome therapy — and the proper administration — is genuinely successful, more research is required, he continued.

Conclusion

The gut microbiome appears to have a significant impact on host immunity and therapeutic response in cancer, either locally within the tumour microenvironment or via systemic antiviral immune responses, according to strong evidence from preclinical and clinical research. The latter is most likely the reason why the gut microbiota is able to control how the body reacts to immunotherapy and traditional chemotherapeutic drugs, eventually having a variety of effects on patient outcomes.

REFERENCES:

For more details, kindly visit below.